Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications - PubMed

Review

Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications

Aristea K Batsali et al. Curr Stem Cell Res Ther. 2013 Mar.

Abstract

In recent years there seems to be an unbounded interest concerning mesenchymal stem cells (MSCs). This is mainly attributed to their exciting characteristics including long-term ex vivo proliferation, multilineage potential and immunomodulatory properties. In this regard MSCs emerge as attractive candidates for various therapeutic applications. MSCs were originally isolated from the bone marrow (BM) and this population is still considered as the gold standard for MSC applications. Nevertheless the BM has several limitations as source of MSCs, including MSC low frequency in this compartment, the painful isolation procedure and the decline in MSC characteristics with donor's age. Thus, there is accumulating interest in identifying alternative sources for MSCs. To this end MSCs obtained from the Wharton's Jelly (WJ) of umbilical cords (UC) have gained much attention over the last years since they can be easily isolated, without any ethical concerns, from a tissue which is discarded after birth. Furthermore WJ-derived MSCs represent a more primitive population than their adult counterparts, opening new perspectives for cell-based therapies. In this review we will at first give an overview of the biology of WJ-derived UC-MSCs. Then their potential application for the treatment of cancer and immune mediated disorders, such graft versus host disease (GVHD) and systemic lupus erythematosus (SLE) will be discussed, and finally their putative role as feeder layer for ex vivo hematopoietic stem cell (HSC) expansion will be pointed out.

Similar articles

• Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.

  Batsali AK, Pontikoglou C, Koutroulakis D, Pavlaki KI, Damianaki A, Mavroudi I, Alpantaki K, Kouvidi E, Kontakis G, Papadaki HA. Batsali AK, et al. Stem Cell Res Ther. 2017 Apr 26;8(1):102. doi: 10.1186/s13287-017-0555-9. Stem Cell Res Ther. 2017. PMID: 28446235 Free PMC article.

• Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.

  Lo Iacono M, Anzalone R, La Rocca G, Baiamonte E, Maggio A, Acuto S. Lo Iacono M, et al. Stem Cell Rev Rep. 2017 Feb;13(1):35-49. doi: 10.1007/s12015-016-9702-4. Stem Cell Rev Rep. 2017. PMID: 27853939 Review.

• Human Wharton's jelly mesenchymal stem cells: properties, isolation and clinical applications.

  Borys-Wójcik S, Brązert M, Jankowski M, Ożegowska K, Chermuła B, Piotrowska-Kempisty H, Bukowska D, Antosik P, Pawelczyk L, Nowicki M, Jeseta M, Kempisty B. Borys-Wójcik S, et al. J Biol Regul Homeost Agents. 2019 Jan-Feb,;33(1):119-123. J Biol Regul Homeost Agents. 2019. PMID: 30729769

• Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.

  Bharti D, Shivakumar SB, Park JK, Ullah I, Subbarao RB, Park JS, Lee SL, Park BW, Rho GJ. Bharti D, et al. Cell Tissue Res. 2018 Apr;372(1):51-65. doi: 10.1007/s00441-017-2699-4. Epub 2017 Dec 4. Cell Tissue Res. 2018. PMID: 29204746 Free PMC article.

• Characteristics and clinical applications of Wharton's jelly-derived mesenchymal stromal cells.

  Liau LL, Ruszymah BHI, Ng MH, Law JX. Liau LL, et al. Curr Res Transl Med. 2020 Jan;68(1):5-16. doi: 10.1016/j.retram.2019.09.001. Epub 2019 Sep 19. Curr Res Transl Med. 2020. PMID: 31543433 Review.

Cited by

• Multipotent fetal stem cells in reproductive biology research.

  Rosner M, Horer S, Feichtinger M, Hengstschläger M. Rosner M, et al. Stem Cell Res Ther. 2023 Jun 7;14(1):157. doi: 10.1186/s13287-023-03379-4. Stem Cell Res Ther. 2023. PMID: 37287077 Free PMC article. Review.

• Mesenchymal stem cells from different sources show distinct therapeutic effects in hyperoxia-induced bronchopulmonary dysplasia in rats.

  Xie Y, Chen F, Jia L, Chen R, Zhang VW, Zhong X, Wang D. Xie Y, et al. J Cell Mol Med. 2021 Sep;25(17):8558-8566. doi: 10.1111/jcmm.16817. Epub 2021 Jul 29. J Cell Mol Med. 2021. PMID: 34322990 Free PMC article.

• Tissue engineering strategies for spiral ganglion neuron protection and regeneration.

  Zhang B, Hu Y, Du H, Han S, Ren L, Cheng H, Wang Y, Gao X, Zheng S, Cui Q, Tian L, Liu T, Sun J, Chai R. Zhang B, et al. J Nanobiotechnology. 2024 Jul 31;22(1):458. doi: 10.1186/s12951-024-02742-8. J Nanobiotechnology. 2024. PMID: 39085923 Free PMC article. Review.

• Effects of human umbilical cord-derived mesenchymal stem cells on hematologic malignancies.

  Li Q, Pang Y, Liu T, Tang Y, Xie J, Zhang B, Chen H. Li Q, et al. Oncol Lett. 2018 May;15(5):6982-6990. doi: 10.3892/ol.2018.8254. Epub 2018 Mar 13. Oncol Lett. 2018. PMID: 29731869 Free PMC article.

• Characterization of Tunneling Nanotubes in Wharton's jelly Mesenchymal Stem Cells. An Intercellular Exchange of Components between Neighboring Cells.

  Sanchez V, Villalba N, Fiore L, Luzzani C, Miriuka S, Boveris A, Gelpi RJ, Brusco A, Poderoso JJ. Sanchez V, et al. Stem Cell Rev Rep. 2017 Aug;13(4):491-498. doi: 10.1007/s12015-017-9730-8. Stem Cell Rev Rep. 2017. PMID: 28214945

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Bentham Science Publishers Ltd.
  • Ingenta plc

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Health Information